ADRIBLASTINE 50 mg, powder for solution for injection in a vial bottle
Active ingredients: Doxorubicin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintraveineuse;intravésicale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADRIBLASTINE 50 mg, poudre pour solution injectable en flacon
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse;intravésicale
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1993
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64367525CIP73340825CIP133400933408251Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DOXORUBICINE (CHLORHYDRATE DE)poudre | 50 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.